ArticleBiomedicines2024

Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.

Igor Aurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.